SITRYX THERAPEUTICS LIMITED
LONDON

Hellopages » Greater London » Camden » WC2B 6ST

Company number 10366466
Status Active
Incorporation Date 8 September 2016
Company Type Private Limited Company
Address 71 KINGSWAY, LONDON, UNITED KINGDOM, WC2B 6ST
Home Country United Kingdom
Nature of Business 74909 - Other professional, scientific and technical activities n.e.c.
Phone, email, etc

Since the company registration three events have happened. The last three records are Appointment of Ms Catherine Elizabeth Bingham as a director on 1 February 2017; Current accounting period extended from 30 September 2017 to 31 December 2017; Incorporation Statement of capital on 2016-09-08 GBP .01 MODEL ARTICLES ‐ Model articles adopted . The most likely internet sites of SITRYX THERAPEUTICS LIMITED are www.sitryxtherapeutics.co.uk, and www.sitryx-therapeutics.co.uk. The predicted number of employees is 1 to 10. The company’s age is nine years and one months. The distance to to Battersea Park Rail Station is 2.9 miles; to Brondesbury Park Rail Station is 4.3 miles; to Barnes Bridge Rail Station is 6.5 miles; to Beckenham Hill Rail Station is 7.7 miles is 2.7 miles. This is straight distance. Please bear in mind the walking distance could be longer.Sitryx Therapeutics Limited is a Private Limited Company. The company registration number is 10366466. Sitryx Therapeutics Limited has been working since 08 September 2016. The present status of the company is Active. The registered address of Sitryx Therapeutics Limited is 71 Kingsway London United Kingdom Wc2b 6st. . ASHRAFIAN, Houman, Professor is a Director of the company. BINGHAM, Catherine Elizabeth is a Director of the company. TINSLEY, Emma is a Director of the company. The company operates in "Other professional, scientific and technical activities n.e.c.".


Current Directors

Director
ASHRAFIAN, Houman, Professor
Appointed Date: 08 September 2016
50 years old

Director
BINGHAM, Catherine Elizabeth
Appointed Date: 01 February 2017
60 years old

Director
TINSLEY, Emma
Appointed Date: 08 September 2016
38 years old

Persons With Significant Control

Professor Houman Ashrafian
Notified on: 8 September 2016
50 years old
Nature of control: Ownership of shares – 75% or more

SITRYX THERAPEUTICS LIMITED Events

14 Feb 2017
Appointment of Ms Catherine Elizabeth Bingham as a director on 1 February 2017
14 Feb 2017
Current accounting period extended from 30 September 2017 to 31 December 2017
08 Sep 2016
Incorporation
Statement of capital on 2016-09-08
  • GBP .01
  • MODEL ARTICLES ‐ Model articles adopted